Related Products
|
||||||
About
Plug’n play API to integrate with your diabetes management platform. Personalized therapeutic education. Better insights on BGL fluctuations. Real-time prediction to anticipate risks. Allow for more personalization and better regulation of the system. Handle complex living phases with rapid glucose changes. Telemedicine & retrospective analysis. Decision-support for patients. Hillo is currently working on the next versions of its AI technology, a therapeutic recommendation system to anticipate and prevent hypoglycemia and hyperglycemia, whose CE mark class IIB is planned for 2020, and the new generation of artificial pancreas(AP) for 2021, which will help overcome the main limitations of current AP systems thanks to the ultra-personalization provided by machine learning. The first self-learning artificial intelligence for predicting blood glucose levels to obtain CE mark as a medical device.
|
About
uMotif is a modern eCOA/ePRO and eConsent platform designed to power clinical and real-world research. Developed in collaboration with patients, the platform delivers unrivaled engagement, transforming the speed, quality, and accuracy of data. By combining uMotif's eCOA/ePRO with continuous glucose monitoring data capture, the platform delivered unprecedented data compliance rates for a pan-European diabetes study. In an immunology study, the patient-centered eCOA/ePRO solution helped the sponsor complete data capture requirements six months early. In an FDA-required CNS study, participants were engaged to capture submission-ready ePRO through their own devices. uMotif has always designed for patients first, with a relentless focus on understanding the patient journey and what drives patient behavior. This deep knowledge allows the design of software that best meets the needs of patients and delivers exceptionally high levels of engagement to study sponsors.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Healthcare providers and clinical professionals looking for an AI solution to predict blood glucose levels
|
Audience
Biotech organizations looking for a patient-centered platform to enhance engagement and data quality in clinical and real-world research
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Supported
|
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
No information available.
Free Version
Not Supported
Free Trial
Supported
|
Pricing
No information available.
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Supported
|
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Supported
In Person
Supported
|
|||||
Company InformationHillo
France
www.hillo.ai/
|
Company InformationuMotif
Founded: 2012
United Kingdom
umotif.com
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|